##semicolon##
pharmaceutical pricing, income level, affordability, innovation, drug availability, price control, pharmacy sales.##submission.citations##
Vogler, S., Zimmermann, N., & Habl, C. (2013). Price comparison of high-cost medicines in European countries. Health Policy, 112(3), 253–260. https://doi.org/10.1016/ j.healthpol.2013.07.013
Kaplan, W. A., Wirtz, V. J., Mantel-Teeuwisse, A., Stolk, P., Duthey, B., & Laing, R. (2013). Priority medicines for Europe and the world update report. World Health Organization. https://www.who.int
Godman, B., Wettermark, B., van Woerkom, M., Fraeyman, J., Alvarez-Madrazo, S., & Berg, C. (2014). Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Frontiers in Pharmacology, 5, 106. https://doi.org/10.3389/fphar.2014.00106
Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., & Reich, M. R. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403–476. https://doi.org/10.10 16/S0140-6736(16)31599-9
Espin, J., & Rovira, J. (2007). Analysis of differences and commonalities in pricing and reimbursement systems in EU Member States. European Commission. https://ec.europa.eu
Nguyen, T. A., Knight, R., Roughead, E. E., Brooks, G., & Mant, A. (2015). Policy options for pharmaceutical pricing and purchasing: Issues for low-and middle-income countries. Health Policy and Planning, 30(2), 267–280. https://doi.org/10.1093/heapol/czu110
Kanavos, P., Seeley, E., & Vandoros, S. (2009). Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium. LSE Health.
Bigdeli, M., Peters, D. H., Wagner, A. K., & Laing, R. (2014). Medicines in health systems: advancing access, affordability and appropriate use. World Health Organization. https:// www.who.int/publications/i/item/9789241506748
IMS Institute for Healthcare Informatics. (2015). Delivering on the Potential of Biosimilar Medicines: The Role of Functioning Competitive Markets. https://www.iqvia.com
World Health Organization. (2021). Global spending on health: Weathering the storm. Geneva: WHO. https://www.who.int/ publications/i/item/9789240043053